diabetes – Page 4 – media

Medial EarlySign’s AI scans medical records for diabetes warning signs

A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
- Source: PharmaPhorum
- 595
- February 7, 2018
AI diabetes NHS Researches
Seven medicines leap closer to EU approval

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has put forward seven new medicines for approval in the region, including new treatment options for haemophilia A, diabetes, and a very rare genetic disorder.
- Source: pharmatimes
- 1,032
- January 30, 2018
CHMP diabetes EMA haemophilia A Hemlibra polices Roche
J&J attracts Chinese interest for diabetes business in potential $3B to $4B deal

Chinese bidders are circling a diabetes care business owned by the world's largest health-care company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters.
- Source: Cnbc;
- 500
- January 19, 2018
diabetes Market Views
Depression medication initiation may lower oral antidiabetic drug adherence in diabetes

Adults with type 2 diabetes and major depressive disorders who begin using second-generation antipsychotics are more likely to have at least a 10% decline in oral antidiabetic drug use 180 to 365 days after initiation compared with nonusers of second-generation antipsychotics, according to a study.
- Source: Healio
- 642
- January 12, 2018
antipsychotics diabetes Researches
Med-tech startup Metavention raises $65M, names new CEO

Metavention Inc., a startup developing a medical device to treat Type 2 diabetes, has closed on $65 million in venture capital and named former Torax Medical Inc. CEO Todd Berg its top executive
- Source: Business Journal
- 648
- January 10, 2018
Company Insight diabetes medical device
Triple drug treatment combo shows promise in adult leukemia

A triple-drug focused remedy method may provide an efficient new treatment choice for power lymphocytic leukemia (CLL) that reduces the chance for the lengthy-time period unintended effects skilled with chemotherapy and is given for a restricted time, not as a day by day lifetime drug remedy.
- Source: medical-newspaper
- 587
- December 21, 2017
Chemotherapy diabetes Researches triple-drug
Are You Doing A Good Job In Bed?

A lack of sleep has been linked to high blood pressure and other cardiovascular ailments, mental health conditions like depression and weight-related issues such as obesity and diabetes.
- Source: msn
- 673
- December 20, 2017
diabetes high blood pressure obesity Researches sleep
FDA Approves Admelog, the First Short-acting “Follow-on” Insulin Product to Treat Diabetes

The U.S. Food and Drug Administration(FDA) approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a “follow-on” product (submitted through the agency’s 505(b)(2) pathway).
- Source: fda.gov
- 629
- December 13, 2017
Admelog blood sugar diabetes New Approvals
Type 2 diabetes may be reversible suggests new research

A UK trial study has found that type 2 diabetes could potentially be reversed through weight loss, and with the long-term support of a medical professional.
- Source: msn.com
- 537
- December 12, 2017
diabetes weight loss
Health2Sync raises $6M to expand its diabetes tracking and management service in Asia

Health2Sync, a Taiwan-headquartered company that offers a diabetes tracking service, has closed a $6 million Series B round aimed at expanding its business in Japan and other markets in Asia.
- Source: drugdu
- 510
- December 11, 2017
diabetes diabetes tracking service Health2Sync Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.